Related Experiment Videos
Interferon regulatory factor-1 and -2 expression in human melanoma specimens
J K Lowney1, L D Boucher, P E Swanson
1Department of Surgery, Washington University, St. Louis, Missouri 63110, USA.
Annals of Surgical Oncology
|September 24, 1999
Summary
Interferon regulatory factor (IRF)-1 and IRF-2 were identified in human melanomas. IRF-1 expression correlated with less advanced melanoma, suggesting a tumor-suppressing role.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Interferon regulatory factor (IRF)-1 and IRF-2 are transcription factors involved in the interferon-gamma response.
- IRF-1 promotes tumor suppression, while IRF-2 opposes its activity.
- Previous studies showed IRF-1's tumor-suppressing effects in models, but its expression in human tumors was uninvestigated.
Purpose of the Study:
- To investigate the expression of IRF-1 and IRF-2 in human melanoma tissues.
- To correlate IRF-1 and IRF-2 expression with melanoma stage and characteristics.
Main Methods:
- Archival tissue specimens from 38 human melanomas were analyzed.
- Immunohistochemical staining was performed using anti-IRF-1 and anti-IRF-2 antibodies.
- Avidin-biotin-peroxidase complex technique with epitope retrieval was employed.
Main Results:
- IRF-1 and IRF-2 expression was detected in 29 of 38 melanoma specimens.
- IRF-1 staining was significantly correlated with less advanced disease stages.
- Superficial spreading and in situ melanomas showed more frequent IRF-1 staining than nodular or metastatic lesions.
Conclusions:
- This study demonstrates the presence of IRF-1 and IRF-2 in human melanomas via immunohistochemistry.
- IRF-1 expression is associated with less aggressive melanoma phenotypes.
- The findings support the potential tumor-suppressing role of IRF-1 in melanoma, aligning with experimental predictions.